Evidence map›Paper›PMID 31084320›Full record

ArticleStroke2019

Getting the Gist Across Is Enough for Informed Consent for Acute Stroke Thrombolytics.

Lesli E Skolarus, Alison O'Brien, William J Meurer, Brian J Zikmund Fisher

Abstract readEditorial
In one paragraph

Article in Stroke, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Stroke Thrombolysis.Circulation. Cardiovascular quality and outcomes · 2019
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lesli E SkolarusFrom the Stroke Program (L.E.S., A.O., W.J.M.) Medicine, University of Michigan Medical School, Ann Arbor.
Alison O'BrienFrom the Stroke Program (L.E.S., A.O., W.J.M.) Medicine, University of Michigan Medical School, Ann Arbor.
William J MeurerFrom the Stroke Program (L.E.S., A.O., W.J.M.) Medicine, University of Michigan Medical School, Ann Arbor.
Brian J Zikmund FisherDepartment of Health Behavior of Health Education, University of Michigan School of Public Health, Ann Arbor (L.E.S., A.O., B.J.Z.F.).

Funding

A Community Based Participatory Trial to Increase Stroke TreatmentU01MD010579 · NIMHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BROWN, DEVIN L · 2016 to 2020
$2.8M
NIMHD NIH HHS U01 MD010579
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Informed ConsentFibrinolytic AgentsHumansStrokeFibrinolytic Agentsdecision-makingemergency medicineinformed consentneurologyrisktissue-type plasminogen activator

Identifiers

PMID31084320
PMCPMC6538464

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.